Increased cholesterol efflux in apolipoprotein AI (ApoAI)-producing macrophages as a mechanism for reduced atherosclerosis in ApoAI(-/-) mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 21, Issue 11, 2001, Pages 1790-1795

  Major, Amy S ^a   Dove, Dwayne E ^a   Ishiguro, Hiroyuki ^a   Yan, Ru Su ^a   Brown, Abigail M ^a   Liu, Lily ^a   Carter, Kathy J ^a   Linton, MacRae F ^a   Fazio, Sergio ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ApoAI; Foam cell; Macrophage; Transgenic mice

Indexed keywords

APOLIPOPROTEIN A1; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTERY WALL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; DIET; ENZYME LINKED IMMUNOSORBENT ASSAY; FOAM CELL; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; WESTERN BLOTTING;

EID: 0035571680     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/hq1101.097798     Document Type: Article

References (39)

1. High density lipoprotein, atherosclerosis, ischaemic heart disease
2. Familial hypoalphalipoproteinemia in premature coronary artery disease
3. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses
4. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI
5. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree
6. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E
7. Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice
8. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells
9. The role of high-density lipoprotein and lipid-soluble antioxidant vitamins in inhibiting low-density lipoprotein oxidation
10. HDL and apoA prevent cell death of endothelial cells induced by oxidized LDL
11. High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules
12. Hydrolysis and excretion of cytoplasmic cholesteryl esters by macrophages: Stimulation by high density lipoprotein and other agents
13. Cell biology of atherosclerosis
14. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection
15. Targeted disruption of class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice
16. CD36, a novel receptor for oxidized low-density lipoproteins, is highly expressed on lipid-laden macrophages in human atherosclerotic aorta
17. A direct role for the macrophage low density lipoprotein receptor in atherosclerotic lesion formation
18. Structures and functions of multiligand lipoprotein receptors: Macrophage scavenger receptors and LDL receptor-related protein (LRP)
19. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease
20. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
21. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1
22. Interaction of free apolipoproteins with macrophages
23. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway
24. Expression of heterologous human apolipoprotein E by J774 macrophages enhances cholesterol efflux to HDL3
25. Retroviral gene therapy in apoE-deficient mice: apoE expression in the artery wall reduces early foam cell lesion formation
26. Scavenger receptor A gene regulatory elements target gene expression to macrophages and foam cells of atherosclerotic lesions
27. Type III hyperlipoproteinemic phenotype in transgenic mice expressing dysfunctional apolipoprotein E
28. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts
29. Increased atherosclerosis in C57BL/6 mice reconstituted with apolipoprotein E null macrophages
30. Prevention of atherosclerosis in apoE deficient mice by bone marrow transplantation
31. Apolipoprotein E-dependent cholesterol efflux from macrophages: Kinetic study and divergent mechanisms for endogenous versus exogenous apolipoprotein E
32. Cyclodextrins as catalysts for the removal of cholesterol from macrophage foam cells
33. Proteolytic processing of human preproapolipoprotein A-I: A proposed defect in the conversion of pro A-I to A-I in Tangier's disease
34. ApoAI reduces free cholesterol accumulation in atherosclerotic lesions of apoE-deficient mice transplanted with apoE-expressing macrophages
35. Somatic gene transfer of human apoA-I inhibits atherosclerosis progression in mouse models
36. Production of cholesterol-enriched nascent high density lipoproteins by human monocyte-derived macrophages is a mechanism that contributes to macrophage cholesterol efflux
37. 3
38. Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice
39. Role of apolipoproteins in cholesterol efflux from macrophages to lipid microemulsions: Proposal of a putative model for the pre-beta high-density lipoprotein pathway